Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2004 June;56(2) > Minerva Urologica e Nefrologica 2004 June;56(2):173-88

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

REVIEWS  


Minerva Urologica e Nefrologica 2004 June;56(2):173-88

language: English

The treatment of non-metastatic prostate cancer with external beam radiation therapy

Horwitz E. M. 1, Feigenberg S. J. 1, Uzzo R. G. 2

1 Departments of Radiation Oncology
2 Urologic Oncology Fox Chase Cancer Center, Philadelphia, PA, USA


PDF  


Multiple treatment options exist for men with non-metastatic prostate cancer. For nearly 50 years, external beam radiation therapy (EBRT) has been an important means of treating men with this disease. Improvements in technology and better use of pre-treatment variables including prostate specific antigen (PSA), Gleason score and prediction nomograms have steadily improved biochemical and clinical outcomes. This article reviews the current status of EBRT in the treatment of prostate cancer. Differences in technique as well as clinical results using conventional, 3D conformal and intensity modulated radiation therapy are compared and contrasted. The appropriate use of adjuvant hormones as well as the complications of these treatments will also be discussed.

top of page

Publication History

Cite this article as

Corresponding author e-mail